MX2018000421A - Composiciones de retinoides topicos. - Google Patents

Composiciones de retinoides topicos.

Info

Publication number
MX2018000421A
MX2018000421A MX2018000421A MX2018000421A MX2018000421A MX 2018000421 A MX2018000421 A MX 2018000421A MX 2018000421 A MX2018000421 A MX 2018000421A MX 2018000421 A MX2018000421 A MX 2018000421A MX 2018000421 A MX2018000421 A MX 2018000421A
Authority
MX
Mexico
Prior art keywords
compositions
present application
application relates
topical
topical retinoid
Prior art date
Application number
MX2018000421A
Other languages
English (en)
Inventor
Okumu Franklin
Kandavilli Sateesh
M Bankar Manish
Kumar Dolai Sujit
Original Assignee
Dr Reddy´S Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddy´S Laboratories Ltd filed Critical Dr Reddy´S Laboratories Ltd
Publication of MX2018000421A publication Critical patent/MX2018000421A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C19/00—Dental auxiliary appliances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C19/00—Dental auxiliary appliances
    • A61C19/06—Implements for therapeutic treatment
    • A61C19/08—Implements for therapeutic treatment combined with anaesthetising implements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dentistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente solicitud se refiere a composiciones tópicas. En particular, la presente solicitud se refiere a una composición tópica que comprende retinoide como agente activo, y excipientes farmacéuticamente aceptables, y un proceso de preparación de tales composiciones. Además, la presente solicitud se refiere a un método para utilizar composiciones tópicas para el tratamiento de trastornos de la piel tales como acné, rosácea, psoriasis, etc.
MX2018000421A 2015-07-13 2016-07-13 Composiciones de retinoides topicos. MX2018000421A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562191937P 2015-07-13 2015-07-13
PCT/US2016/042168 WO2017011600A1 (en) 2015-07-13 2016-07-13 Topical retinoid compositions

Publications (1)

Publication Number Publication Date
MX2018000421A true MX2018000421A (es) 2018-05-17

Family

ID=56550383

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018000421A MX2018000421A (es) 2015-07-13 2016-07-13 Composiciones de retinoides topicos.

Country Status (15)

Country Link
US (5) US9707216B2 (es)
EP (1) EP3322401A1 (es)
JP (1) JP6666992B2 (es)
KR (1) KR20180026740A (es)
CN (1) CN108024954A (es)
AU (1) AU2016294504B2 (es)
BR (1) BR112018000734A2 (es)
CA (1) CA2992107A1 (es)
CO (1) CO2018001375A2 (es)
EA (1) EA034808B1 (es)
MX (1) MX2018000421A (es)
NZ (1) NZ738815A (es)
RU (1) RU2699027C2 (es)
WO (1) WO2017011600A1 (es)
ZA (1) ZA201800080B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011064631A1 (en) 2009-10-02 2011-06-03 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
EP3322401A1 (en) * 2015-07-13 2018-05-23 Dr. Reddy's Laboratories Ltd. Topical retinoid compositions
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US9987239B1 (en) * 2017-03-14 2018-06-05 Rey Ventures, LLC Pharmaceutical retinoid preparation for topical use
WO2019068096A1 (en) 2017-09-29 2019-04-04 Rodan & Fields, Llc COMPOSITIONS CONTAINING RETINALDEHYDE AND METHODS OF USE
CN113164352A (zh) * 2018-10-19 2021-07-23 塔普克斯制药公司 视黄醇制剂及其皮肤治疗方法
MX2022007424A (es) * 2019-12-20 2022-09-19 Advansix Resins & Chemicals Llc Tensioactivos para uso en productos para el cuidado de la salud.
WO2022165254A1 (en) * 2021-01-28 2022-08-04 Chemistryrx Kits for dermal care
DE102022212093A1 (de) * 2022-11-15 2024-05-16 Beiersdorf Aktiengesellschaft Waschformulierung gegen Akne

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965275A (en) * 1974-02-11 1976-06-22 Commercial Solvents Corporation Composition and method
FR2350095A1 (fr) * 1976-05-03 1977-12-02 Oreal Compositions destinees a la coloration de la peau a base de derives de la pyridine
US4154823A (en) * 1976-06-10 1979-05-15 Schutt Steven R Skin treatment compositions and methods of using same
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
US5445823A (en) * 1994-10-20 1995-08-29 The Procter & Gamble Company Dermatological compositions and method of treatment of skin lesions therewith
US5690947A (en) * 1996-08-30 1997-11-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Borage seed oil as an anti-irritant in compositions containing hydroxy acids or retinoids
US6338855B1 (en) 1996-10-25 2002-01-15 The Procter & Gamble Company Cleansing articles for skin and/or hair which also deposit skin care actives
US5855893A (en) 1997-02-14 1999-01-05 Elizabeth Arden Co., Division Of Conopco, Inc. Trichodesma lanicum seed extract as an anti-irritant in compositions containing hydroxy acids or retinoids
US6974807B1 (en) 1997-02-20 2005-12-13 Allergan, Inc. Tazarotene and corticosteroid treatment for psoriasis
DE69808790T3 (de) * 1997-09-12 2009-07-16 The Procter & Gamble Co., Cincinnati Hautreinigungs- und konditionierungsartikel für haut und haar
US6036963A (en) * 1998-02-26 2000-03-14 Chesebrough-Ponds's Usa Co., Division Of Conopco, Inc. Gluconolactones and glucarolactones as anti-irritants in cosmetic compositions
US6017938A (en) 1998-07-28 2000-01-25 Bershad; Susan Short contact treatment for acne
DE69934410T2 (de) * 1998-07-28 2007-09-27 Bershad, Susan Behandlung von akne und lichtbedingter alterung durch kurzzeitbehandlung mit topischen retinoiden
FR2787322B1 (fr) * 1998-12-18 2002-10-18 Galderma Res & Dev Emulsion huile-dans-eau comprenant un agent actif micronise et un systeme emulsionnant approprie
JP2000212082A (ja) * 1999-01-26 2000-08-02 Showa Denko Kk 皮膚用剤
US6114348A (en) * 1999-03-10 2000-09-05 Weber; Paul J. Method of treating warts using tazarotene
US6277881B1 (en) * 1999-05-27 2001-08-21 Unilever Home & Personal Care, Usa, Division Of Conopco, Inc. Turmeric as an anti-irritant in compositions containing hydroxy acids or retinoids
US6385623B1 (en) * 1999-11-12 2002-05-07 Dell Usa, L.P. System and method for ensuring proper execution of scheduled file updates
US6387383B1 (en) 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US6495602B1 (en) * 2001-12-13 2002-12-17 Bradley Pharmaceuticals, Inc. Topical pharmaceutical base with anti-pruritic and/or anti-inflammatory drugs
US20060233721A1 (en) * 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US6974570B1 (en) * 2002-10-30 2005-12-13 Griffith Dana K Shaving lotion kit and method of preparing skin and unwanted hair for shaving
ES2637956T3 (es) * 2003-01-24 2017-10-18 Stiefel Research Australia Pty Ltd Espuma farmacéutica
EP1696868A1 (en) * 2003-07-18 2006-09-06 Hill Dermaceuticals, Inc. Topical skin care composition containing refined peanut oil
MXPA06001381A (es) * 2003-08-04 2006-05-19 Foamix Ltd Vehiculo de espuma que contiene un gelificante copolimerico anfifilico.
FR2871377B1 (fr) 2004-06-11 2007-08-24 Galderma Res & Dev Gel depigmentant hydroalcoolique comprenant du mequinol et de l'adapalene
WO2006065991A2 (en) 2004-12-17 2006-06-22 Dr. Reddy's Laboratories Ltd. Dispersion for delivering active agents
FR2894821B1 (fr) * 2005-12-15 2008-02-29 Galderma Res & Dev Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations
FR2920967B1 (fr) * 2007-09-14 2009-10-23 Sederma Soc Par Actions Simpli Utilisation de l'hydroxymethionine en tant qu'actif anti age
PT2400951T (pt) 2009-02-25 2018-11-26 Mayne Pharma Llc Composições de espuma tópica
ES2812451T3 (es) * 2015-06-18 2021-03-17 Bausch Health Ireland Ltd Composiciones tópicas que comprenden un corticosteroide y un retinoide para tratar la psoriasis
EP3322401A1 (en) * 2015-07-13 2018-05-23 Dr. Reddy's Laboratories Ltd. Topical retinoid compositions

Also Published As

Publication number Publication date
NZ738815A (en) 2019-10-25
US10716781B2 (en) 2020-07-21
RU2699027C2 (ru) 2019-09-03
WO2017011600A1 (en) 2017-01-19
AU2016294504B2 (en) 2019-07-18
US20180177774A1 (en) 2018-06-28
RU2018105091A (ru) 2019-08-13
KR20180026740A (ko) 2018-03-13
RU2018105091A3 (es) 2019-08-13
CO2018001375A2 (es) 2018-06-20
EA034808B1 (ru) 2020-03-24
BR112018000734A2 (pt) 2018-09-04
AU2016294504A1 (en) 2018-01-25
US11026934B2 (en) 2021-06-08
US9707216B2 (en) 2017-07-18
CA2992107A1 (en) 2017-01-19
US20170281610A1 (en) 2017-10-05
EA201890218A1 (ru) 2018-09-28
US20210161875A1 (en) 2021-06-03
ZA201800080B (en) 2020-02-26
JP2018524366A (ja) 2018-08-30
US20190224181A1 (en) 2019-07-25
US20170014398A1 (en) 2017-01-19
JP6666992B2 (ja) 2020-03-18
CN108024954A (zh) 2018-05-11
US9931328B2 (en) 2018-04-03
EP3322401A1 (en) 2018-05-23

Similar Documents

Publication Publication Date Title
MX2018000421A (es) Composiciones de retinoides topicos.
MX2019005379A (es) Derivado de pirazolo-heteroarilo, metodo de preparacion y uso medico del mismo.
MX2016011841A (es) Composiciones topicas de corticosteroides.
CL2015000655A1 (es) Nanopartículas terapéuticas que comprenden un agente terapéutico y métodos para realizarlas y usarlas
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
NZ744323A (en) Compositions comprising 15-hepe and methods of using the same
MX2015013148A (es) Nuevos compuestos de bencensulfonamida, metodo para sintetizar los mismos, y uso de los mismos en medicina asi como tambien en cosmeticos.
MX2016003951A (es) Composicion para rocio topica de halobetasol.
SA113340494B1 (ar) تركيبة لعلاج اضطرابات أيضية
MX2016008397A (es) Composicion para usarse en el tratamiento de tos persistente.
PH12015501739B1 (en) Topical antifungal composition for treating onychomycosis
MX2020001428A (es) Composiciones de grapiprant y metodos para usar las mismas.
GB201117490D0 (en) Anti-inflammatory compounds
MX366309B (es) Composicion farmaceutica para el tratamiento de inflamacion y dolor.
MX2016005645A (es) Composicion farmaceutica topica de acitretina.
MX2016003950A (es) Composicion para rocio topica de halobetasol sin propelente.
MX368640B (es) Composición farmacéutica para tratar inflamación y dolor.
AU2017259411A1 (en) Treating activated dermal conditions with agents that target energy metabolism
PH12016500471A1 (en) Method to treat onychomycosis by hydroxypropyl chitosan
PH22017000460U1 (en) A topical composition
UA96802U (uk) Спосіб лікування інволютивних змін шкіри обличчя, ускладнених грибковою інфекцією роду malassezia
UA88421U (ru) Фармацевтическая композиция "фузипан-дерма" для лечения угревой болезни i-ii стадий
MX2016010919A (es) 4-bencilsulfonil-2-butenonitrilo.